Leading science-driven biopharma company Regeneron Pharmaceuticals, has today announced that it is investing an additional $350 million in its Limerick Industrial Operations and Product Supply (IOPS) bioprocessing campus, which will add another 200 jobs.
The development brings the total expected job creation in the Limerick area to 500 jobs and investment to $650 million by the end of 2017.
The company acquired the former Dell Computer facility in Limerick and achieved planning approval in April 2014 for its first IOPS site outside of the United States. When the investment was initially announced in December 2013, a $300 million investment with 300 jobs was planned for delivery by the end of 2016. With this expansion of scope, the Limerick IOPS campus will house the largest-scale bulk biologics production facility in Ireland.
With approximately 300 full-time employees, 200 contingent workers and 550 construction workers in place, recruitment is underway to bring on additional full-time, high-end specialist jobs in commercial manufacturing, process sciences, quality assurance/control and various support functions for scientists, chemists and technicians. At peak, 1,200 contractors were onsite to support development.
Regeneron’s 400,000 square foot, state-of-the-art biologics production facility in Limerick is now operational with the first production line on track to enter validation before year end 2015.
In addition to IOPS significant operations in Limerick, Regeneron also has a growing multi functional team in Dublin supporting its business in Europe. Regeneron’s total headcount in Ireland is expected to approach 550 by the end of 2017.
The company has worked closely with the Department of Jobs and IDA Ireland on the development of its operations in Ireland.
Click here for details of current job openings in Ireland and Career Opportunities with Regenron.
The CareersPortal Team